Tomoyuki Ishigo

467 total citations
20 papers, 278 citations indexed

About

Tomoyuki Ishigo is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Pharmacology. According to data from OpenAlex, Tomoyuki Ishigo has authored 20 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 9 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in Tomoyuki Ishigo's work include Nutrition and Health in Aging (8 papers), Heart Failure Treatment and Management (5 papers) and Frailty in Older Adults (4 papers). Tomoyuki Ishigo is often cited by papers focused on Nutrition and Health in Aging (8 papers), Heart Failure Treatment and Management (5 papers) and Frailty in Older Adults (4 papers). Tomoyuki Ishigo collaborates with scholars based in Japan and United States. Tomoyuki Ishigo's co-authors include Satoshi Katano, Katsuhiko Ohori, Tetsuji Miura, Takefumi Fujito, Hidemichi Kouzu, Ryohei Nagaoka, Toshiyuki Yano, Akiyoshi Hashimoto, Masayuki Koyama and Ryo Nishikawa and has published in prestigious journals such as The Journal of Clinical Pharmacology, BMC Geriatrics and Circulation Journal.

In The Last Decade

Tomoyuki Ishigo

19 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoyuki Ishigo Japan 10 144 132 62 34 27 20 278
Joanna Jaroch Poland 10 86 0.6× 246 1.9× 76 1.2× 40 1.2× 39 1.4× 45 395
Lidia Cobos-Palacios Spain 9 70 0.5× 41 0.3× 24 0.4× 28 0.8× 41 1.5× 20 225
Christina Al Malouf United States 3 221 1.5× 78 0.6× 81 1.3× 38 1.1× 29 1.1× 6 329
Amidio Testa Italy 6 178 1.2× 57 0.4× 25 0.4× 42 1.2× 15 0.6× 8 273
David Gisi Switzerland 8 138 1.0× 38 0.3× 39 0.6× 18 0.5× 59 2.2× 15 267
Rajiv Sankaranarayanan United Kingdom 13 79 0.5× 314 2.4× 53 0.9× 77 2.3× 32 1.2× 63 479
Sandra Henríquez Chile 6 181 1.3× 26 0.2× 44 0.7× 39 1.1× 39 1.4× 10 314
Nuria Montero-Fernández Spain 7 191 1.3× 89 0.7× 43 0.7× 38 1.1× 139 5.1× 7 377
Francesca Corzato Italy 8 195 1.4× 181 1.4× 32 0.5× 42 1.2× 145 5.4× 9 406
Samira Bahrainy United States 6 222 1.5× 104 0.8× 68 1.1× 42 1.2× 36 1.3× 8 370

Countries citing papers authored by Tomoyuki Ishigo

Since Specialization
Citations

This map shows the geographic impact of Tomoyuki Ishigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Ishigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Ishigo more than expected).

Fields of papers citing papers by Tomoyuki Ishigo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Ishigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Ishigo. The network helps show where Tomoyuki Ishigo may publish in the future.

Co-authorship network of co-authors of Tomoyuki Ishigo

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Ishigo. A scholar is included among the top collaborators of Tomoyuki Ishigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Ishigo. Tomoyuki Ishigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ishigo, Tomoyuki, Toshiyuki Yano, Masayuki Koyama, et al.. (2023). Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5‐Year Retrospective Cohort Study. The Journal of Clinical Pharmacology. 63(6). 654–663. 3 indexed citations
4.
5.
Katano, Satoshi, Toshiyuki Yano, Ryohei Nagaoka, et al.. (2023). Impact of Radar Chart-Based Information Sharing in a Multidisciplinary Team on In-Hospital Outcomes and Prognosis in Older Patients With Heart Failure. Circulation Reports. 5(7). 271–281. 4 indexed citations
6.
Ishigo, Tomoyuki, et al.. (2023). Effect of renal clearance on vancomycin area under the concentration–time curve deviations in critically ill patients. Journal of Infection and Chemotherapy. 29(8). 769–777. 4 indexed citations
7.
Watanabe, Ayako, Satoshi Katano, Toshiyuki Yano, et al.. (2022). Loss of perceived social role, an index of social frailty, is an independent predictor of future adverse events in hospitalized patients with heart failure. Frontiers in Cardiovascular Medicine. 9. 1051570–1051570. 9 indexed citations
8.
Katano, Satoshi, Toshiyuki Yano, Masaki Shimizu, et al.. (2021). Does Renin-Angiotensin System Inhibition Have Impacts on Muscle Mass and Bone Mineral Density in Heart Failure Patients?. ESC Heart Failure. 8(4). 2617–2624. 10 indexed citations
9.
Katano, Satoshi, Toshiyuki Yano, Hidemichi Kouzu, et al.. (2021). Energy intake during hospital stay predicts all-cause mortality after discharge independently of nutritional status in elderly heart failure patients. Clinical Research in Cardiology. 110(8). 1202–1220. 29 indexed citations
10.
Ohori, Katsuhiko, Toshiyuki Yano, Satoshi Katano, et al.. (2021). High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: an explanation of the obesity paradox. BMC Geriatrics. 21(1). 16–16. 41 indexed citations
11.
Fujii, Satoshi, Tomoyuki Ishigo, Yoshihiro Fujiya, et al.. (2021). Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients. Journal of Infection and Chemotherapy. 27(7). 1051–1057. 13 indexed citations
12.
Ishigo, Tomoyuki, et al.. (2021). Efficacy and Safety of Linaclotide in Elderly Patients. YAKUGAKU ZASSHI. 141(2). 255–262. 2 indexed citations
13.
Kouzu, Hidemichi, Satoshi Katano, Toshiyuki Yano, et al.. (2021). Plasma Amino Acid Profiling Improves Predictive Accuracy of Adverse Events in Patients with Heart Failure. ESC Heart Failure. 8(6). 5045–5056. 24 indexed citations
14.
Katano, Satoshi, Toshiyuki Yano, Katsuhiko Ohori, et al.. (2021). Barthel Index Score Predicts Mortality in Elderly Heart Failure　― A Goal of Comprehensive Cardiac Rehabilitation ―. Circulation Journal. 86(1). 70–78. 43 indexed citations
15.
Ohori, Katsuhiko, Toshiyuki Yano, Satoshi Katano, et al.. (2020). Independent Link Between Peripheral Artery Disease and Muscle Wasting in Patients with Heart Failure. ESC Heart Failure. 7(5). 3252–3256. 9 indexed citations
16.
Katano, Satoshi, Toshiyuki Yano, Hidemichi Kouzu, et al.. (2020). Clinical Risk Factors and Prognostic Impact of Osteoporosis in Patients With Chronic Heart Failure. Circulation Journal. 84(12). 2224–2234. 17 indexed citations
17.
Ishigo, Tomoyuki, et al.. (2020). Association Suvorexant and Ramelteon Use with the Risk of Falling: A Retrospective Case-control Study. YAKUGAKU ZASSHI. 140(8). 1041–1049. 6 indexed citations
18.
Yano, Toshiyuki, Satoshi Katano, Hidemichi Kouzu, et al.. (2020). Distinct determinants of muscle wasting in nonobese heart failure patients with and without type 2 diabetes mellitus. Journal of Diabetes. 13(1). 7–18. 13 indexed citations
19.
Ishigo, Tomoyuki, Satoshi Katano, Toshiyuki Yano, et al.. (2020). Overestimation of glomerular filtration rate by creatinine‐based equation in heart failure patients is predicted by a novel scoring system. Geriatrics and gerontology international. 20(8). 752–758. 13 indexed citations
20.
Katano, Satoshi, Akiyoshi Hashimoto, Katsuhiko Ohori, et al.. (2018). Nutritional Status and Energy Intake as Predictors of Functional Status After Cardiac Rehabilitation in Elderly Inpatients With Heart Failure　― A Retrospective Cohort Study ―. Circulation Journal. 82(6). 1584–1591. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joanna Jaroch Breakdown of academic impact, for papers by Lidia Cobos-Palacios Breakdown of academic impact, for papers by Christina Al Malouf Breakdown of academic impact, for papers by Amidio Testa Breakdown of academic impact, for papers by David Gisi Breakdown of academic impact, for papers by Rajiv Sankaranarayanan Breakdown of academic impact, for papers by Sandra Henríquez Breakdown of academic impact, for papers by Nuria Montero-Fernández Breakdown of academic impact, for papers by Francesca Corzato Breakdown of academic impact, for papers by Samira Bahrainy
Rankless by CCL
2026